1. CE: Febrile Neutropenia in the Chemotherapy Patient.
- Author
-
Foley AM and Hoffman M
- Subjects
- Humans, Anti-Bacterial Agents adverse effects, Fever drug therapy, Inpatients, Neoplasms drug therapy, Febrile Neutropenia chemically induced, Febrile Neutropenia drug therapy, Febrile Neutropenia complications
- Abstract
Abstract: Febrile neutropenia is a serious complication of chemotherapy treatment and may present as the only clinical sign of infection. If not addressed in a timely manner, it may progress to multisystem organ failure and may be fatal. Initial assessment of fever in those receiving chemotherapy requires prompt administration of antibiotics, ideally within one hour of presentation. Depending on the clinical status of the patient, antibiotic treatment may occur in the inpatient or outpatient setting. Nurses play an important role in the identification and treatment of patients at high risk for febrile neutropenia through assessment and adherence to clinical practice guidelines. In addition, nurses play an active role in patient education regarding risk factors, protective measures, and signs and symptoms of infection in the immunocompromised oncology patient., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF